Welcome to the Medications page. Please click on the plus-sign (+) to read more about a particular medication. If you are having difficulty reading the page, please visit our text-based page: Text-Based Medication Page.

  • Actemra

    ACTEMRA® is a prescription medicine called an interleukin-6 (IL-6) receptor inhibitor. ACTEMRA® is used to treat adults with moderately to severly active active rheumatoid arthritis (RA) after at least one other medicine called a tumor necrosis factor (TNF) antagonist has been used and did not work well. It is given as a monthly IV infusion.

    For more information about ACTEMRA®, please visit www.actemra.com

  • Benlysta

    BENLYSTA®is a  prescription medication used to treat adults with active systemic lupus  erythematosus (SLE or lupus) who are receiving other lupus medicines

    For more information about BENLYSTA®, please visit www.benlysta.com

  • Boniva

    Boniva is a prescription medicine used to treat or prevent osteoporosis in women after menopause. Boniva helps increase bone mass and helps reduce the chance of having a spinal fracture (break).

    For more information, please read: Boniva Medication Guide (PDF)

  • Cimzia

    CIMZIA® (certolizumab pegol) is an exciting new option in RA therapy which in clinical trial has been shown to reduce pain, stiffness and fatigue as fast as 1 to 2 weeks. Many patients on CIMZIA® experienced lasting relief at both 6 months and 1 year.

    CIMZIA® is a medicine used to treat adults with moderately to severely active Rheumatoid Arthritis and is also approved for Crohn’s disease.

    CIMZIA® is referred to as an “anti-TNF therapy”. By blocking tumor necrosis factor (TNF)-alpha, CIMZIA® helps reduce the inflammation, stiffness and joint damage RA causes.

    CIMZIA® is taken by an injection under the skin. After initial doses, CIMZIA® can be injected every 2 or 4 weeks and may be taken with or without other RA medications like methotrexate.

    For more information about CIMZIA®, please visit www.cimzia.com

  • Cosentyx

    COSENTYX® (secukinumab) is a subcutaneous injection indicated for the treatment of moderate to severe plaque psoriasis in adult patients who are candidates for systemic therapy or phototherapy. It is also indicated for the treatment of adult patients with active psoriatic arthritis and active ankylosing spondylitis.

    For more information on COSENTYX®, go to: www.cosentyxhcp.com

  • Entyvio

    ENTYVIO is a prescription medicine (intravenous; injection) used in adults with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD).

    For more information on ENTYVIO, please visit www.entyvio.com .

  • Orencia

    Joint pain and inflammation can limit your abilities from washing your hair to finishing a project at work. In fact, scientists have studied and identified the impact an illness such as rheumatoid arthritis can have on a person’s health-related quality of life in specific areas. Researchers have assessed these areas using a survey called the SF-36®. The SF-36® asks 36 questions in 8 areas of function about physical and mental aspects of an individual’s health-related quality of life. ORENCIA® has been shown to improve the signs and symptoms of rheumatoid arthritis, slow the advance of joint damage, and help improve physical function.

    Read more about ORENCIA® at www.orencia.com

  • Otezla

    Otezla (apremilast) is a phosphodiesterase 4 (PDE4) inhibitor given as a twice daily pill used to treat adult patients with active psoriatic arthritis and certain types of psoriasis.

    For more information on Otezla, please visit www.otezla.com.

  • Prolia

    Prolia® (denosumab)  is a different way to treat postmenopausal osteoporosis in women who have an increased risk for fractures. Prolia  is one shot, given in your doctor’s office every 6 months, that can help reduce fracture risk and strengthen your bones.

    For more information about Prolia®, please visit www.prolia.com

  • Reclast

    Maintaining your bone health can help you stay strong for your family, friends and the other parts of your active life. Just one annual dose of Reclast, along with daily calcium and Vitamin D, helps to increase your bone density. So your bones can be stronger and better protected.

    For more information, please visit the Reclast® webpage.

  • Remicade

    When taken with methotrexate, REMICADE® can provide quick symptom relief—in as few as 2 weeks for some patients. Of course, the potential impact of RA goes beyond your day-to-day symptoms. So it’s good to know that REMICADE® can also help stop the progression of long-term damage. Individual results may vary.

    Read more about REMICADE® at www.remicade.com

  • Rituxan

    RITUXAN® (rituximab) is a monoclonal antibody used in adults with another prescription medicine called methotrexate, to reduce the signs and symptoms of moderate to severe active RA, after at least one other medicine called a tumor necrosis factor (TNF) inhibitor has not been effective. It is also approved for Granulomatosis with Polyangiitis (GPA or Wegeners) and Microscopic Polyangiitis (MPA), Non-Hodgkins Lymphoma and certain leukemias.

    Read more about RITUXAN® at www.rituxan.com

  • Simponi Aria

    SIMPONI ARIA ® (golimumab) is a 30 minute intravenous nifusion approved for use in patients with moderate to severe RA usually in conjunction with methotrexate.

    For more information on SIMPONI ARIA ®, please visit www.simponiariahcp.com.

  • Stelara

    STELARA® (ustekinumab) is indicated for the treatment of adult patients with active psoriatic arthritis. STELARA® can be used alone or in combination with methotrexate (MTX).It is also indicated for the treatment of adult patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy and also indicated for the treatment of adult patients with moderately to severely active Crohn’s disease who have:
    – failed or were intolerant to treatment with immunomodulators or corticosteroids, but never failed treatment with a tumor necrosis factor (TNF) blocker, or
    – failed or were intolerant to treatment with one or more TNF blockers

    For more information on STELARA®, please visit www.stelarainfo.com .

  • Xeljanz

    XELJANZ is a prescription medicine called a Janus kinase (JAK) inhibitor. XELJANZ is used to treat adults with moderately to severely active rheumatoid arthritis in which methotrexate did not work well.

    Read more about XELJANZ at www.xeljanz.com

  • What we do

    We specialize in a number of treatments. Please visit our Treatments page to read more about what we can do to help you!
    Read More
  • What are you feeling?

    Does your knee hurt? Do you believe you have arthritis? Read more on our Conditions page.
    Read More
  • Hours

    • Monday, Wednesday, Thursday
      8am - 5pm
    • Tuesday
      8am - 6pm
    • Friday
      8am - 12pm